Article Text

Download PDFPDF
Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma
  1. Fangfang Wang, MD*,
  2. Aijun Yu, MD*,
  3. Haichao Xu, MD, PhD,
  4. Xiaojing Zhang, MD*,
  5. Li Li, MD, PhD*,
  6. Hanmei Lou, MD*,
  7. Hua Yu, MD* and
  8. Jun Lin, MD, PhD
  1. * Departments of Gynecologic Oncology,
  2. Musculoskeletal Oncology, Zhejiang Cancer Hospital, and
  3. Obstetrics and Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  1. Address correspondence and reprint requests to Fangfang Wang, MD, Department of Gynecologic Oncology, Zhejiang Cancer Hospital, No 1 Banshan East Rd, Gongshu District, Hangzhou 310000, People's Republic of China. E-mail: wangfangf{at}


Objective This study aims to explore the feasibility of a hysteroscopic procedure combined with progestin therapy in young patients with stage Ia endometrioid carcinoma (EC) to avoid sterilization.

Materials and Methods Eleven young women with stage Ia EC (International Federation of Gynecology and Obstetrics grade 1) who were treated with a hysteroscopic approach combined with progestin from July 2004 to June 2016 were retrospectively analyzed and followed up to monitor their general recovery and pregnancy outcome.

Results The patients' median age was 27.3 years (range, 25–39 years). Comorbidities consisted of primary infertility in 8 patients, polycystic ovary syndrome in 4, uterine fibroids in 2, and diabetes in 1. The results of immunohistochemical analysis were positive for all estrogen and progestin receptors. After treatment, 9 patients attained complete remission, and 2 patients achieved partial remission. The results of peritoneal cytology in 4 patients were negative. As of this writing, 6 of the 11 patients have given birth to 7 infants, and 1 patient had an ectopic pregnancy. Two patients ultimately underwent radical resection. The average follow-up time was 82.3 months (range, 15 to 152 months), and all patients remain disease-free.

Conclusions Hysteroscopic surgery combined with progestin treatment for stage Ia EC in young patients to avoid sterilization was practical and may represent a new option for patients with stage Ia EC who wish to preserve their fertility.

  • Endometrioid carcinoma
  • Fertility preservation
  • Hysteroscopy
  • Progestin

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interest.